Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(4 sites)

United States

University of Illinois Cancer Center, Chicago, Illinois

University of Rochester Medical Center, Rochester, New York

Penn State Cancer Institute, Hershey, Pennsylvania

University of Wisconsin, Madison, Wisconsin